
The biopharmaceutical sector finally regained its footing in 2025. Here are 5 issues that could determine whether the renewed optimism will carry over into the new year.

The biopharmaceutical sector finally regained its footing in 2025. Here are 5 issues that could determine whether the renewed optimism will carry over into the new year.